Harmony Biosciences Holdings (HRMY) Times Interest Earned (2023 - 2026)
Harmony Biosciences Holdings' (HRMY) quarterly Times Interest Earned came in at $2.58 in Q1 2026, down 82.42% year-on-year from $14.66 in Q1 2025, and up 107.33% quarter-over-quarter from -$35.18 in Q4 2025.
Harmony Biosciences Holdings (HRMY) Times Interest Earned (2023 - 2026) Analysis & Trends
Harmony Biosciences Holdings has disclosed Times Interest Earned across 4 years of filings, most recently posting $2.58 for Q1 2026.
- Times Interest Earned for Q1 2026 came in at $2.58, down 82.42% year-over-year; the trailing twelve-month figure through Mar 2026 was -$0.2 (down 101.68% YoY), and the FY2025 annual result was $3.08, down 71.73% from the prior year.
- Times Interest Earned came in at $2.58 for Q1 2026 at Harmony Biosciences Holdings, up from -$35.18 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $18.09 in Q3 2025 to a low of -$35.18 in Q4 2025.
- The 4-year median for Times Interest Earned is $9.2 (2023), against an average of $6.87.
- Peak annual rise in Times Interest Earned reached 172.51% in 2025, while the deepest fall reached 365.71% in 2025.
- Harmony Biosciences Holdings' Times Interest Earned stood at $8.38 in 2023, then jumped by 57.97% to $13.24 in 2024, then plunged by 365.71% to -$35.18 in 2025, then jumped by 107.33% to $2.58 in 2026.
- The last three Times Interest Earned figures came in at $2.58 (Q1 2026), -$35.18 (Q4 2025), and $18.09 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Harmony Biosciences Holdings | 1.92 Bn | 1.28 Bn | 170.88 Mn | 2.58 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.58 |
| Dec 31, 2025 | -35.18 |
| Sep 30, 2025 | 18.09 |
| Jun 30, 2025 | 13.21 |
| Mar 31, 2025 | 14.66 |
| Dec 31, 2024 | 13.24 |
| Sep 30, 2024 | 14.19 |
| Jun 30, 2024 | 4.85 |
| Mar 31, 2024 | 11.47 |
| Dec 31, 2023 | 8.38 |
| Sep 30, 2023 | 9.20 |
| Jun 30, 2023 | 7.54 |
| Mar 31, 2023 | 7.05 |